[Form 4] CareCloud, Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock Insider Trading Activity

Rhea-AI Filing Summary

Director John N. Daly of CareCloud has reported a significant insider transaction, selling 15,000 shares of Common Stock on June 17, 2025 at a weighted average price of $2.11 per share. The transaction prices ranged from $2.10 to $2.14 per share.

Following this disposition, Daly continues to maintain a direct ownership of 61,750 shares of CareCloud common stock. The transaction was executed through multiple trades and was reported via Form 4 filing on June 18, 2025.

Key transaction details:

• Transaction Type: Sale (Disposition)
• Total Transaction Value: Approximately $31,650
• Ownership Type: Direct
• Filing Status: Individual filing

Positive

• None.

Negative

• Director John Daly sold 15,000 shares at an average price of $2.11, reducing his holdings by approximately 19.5% (from 76,750 to 61,750 shares)

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DALY JOHN N

(Last) (First) (Middle)

7 CLYDE ROAD

(Street)

SOMERSET NJ 08873

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CareCloud, Inc. [ CCLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		S		15,000	D	$2.11(1)	61,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.10 to $2.14, inclusive. The reporting person undertakes to provide to any security holder of CareCloud, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

	/s/ Norman Roth Attorney-In-Fact for John Daly	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of CareCloud (CCLDP) did Director John Daly sell on June 17, 2025?

Director John Daly sold 15,000 shares of CareCloud common stock on June 17, 2025.

What was the sale price of CCLDP shares in Director Daly's June 2025 transaction?

The shares were sold at a weighted average price of $2.11, with transactions ranging from $2.10 to $2.14 per share.

How many shares does John Daly still own after his June 2025 CCLDP stock sale?

Following the reported transaction, John Daly still directly owns 61,750 shares of CareCloud stock.

What position does John Daly hold at CareCloud (CCLDP)?

John Daly serves as a Director of CareCloud, Inc., as indicated by the 'X' marked in the Director box on the Form 4 filing.

When was the Form 4 for John Daly's CCLDP stock sale filed with the SEC?

The Form 4 was signed by Norman Roth (Attorney-In-Fact for John Daly) on June 18, 2025, and filed on June 28, 2025.